Table 1.
Parameter | WSC | n | CC | n | p Value |
---|---|---|---|---|---|
Subjects | 20 | 24 | |||
Gender (M/F) | 8/12 | 16/8 | |||
Tumor location (stomach/colorectal) | 6/14 | 8/16 | |||
Tumor stage | |||||
I–II | 9 | 4 | |||
III–IV | 8 | 13 | |||
Age (years) | 61.00 ± 2.35 | 20 | 61.42 ± 2.68 | 24 | 0.90 |
Previous weight | 67.50 ± 2.47 | 20 | 73.55 ± 3.40 | 24 | 0.17 |
Weight (kg) | 65.90 ± 2.79 | 20 | 60.20 ± 2.43 | 24 | 0.13 |
Height (m) | 1.64 [1.56; 1.70] | 20 | 1.70 [1.64; 1.72] | 24 | 0.14 |
BMI (kg/m2) | 24.69 ± 0.77 | 20 | 21.55 ± 0.66 | 24 | 0.003 |
Weight loss (%) | 0.0 [0.0; 0.0] | 20 | 15.12 [8.84; 23.01] | 24 | <0.0001 |
Hemoglobin (g/dL) | 13.10 [12.20; 14.30] | 14 | 11.30 [9.80; 12.00] | 23 | 0.0001 |
Serum C reactive protein (CRP) (mg/L) | 5.07 ± 1.29 | 17 | 9.12 ± 0.91 | 22 | 0.01 |
Serum albumin (mg/dL) | 3.56 ± 0.20 | 17 | 3.25 ± 0.19 | 23 | 0.28 |
CRP/albumin ratio | 0.18 [0.03; 0.32] | 17 | 0.33 [0.15; 0.42] | 22 | 0.009 |
Serum glucose (mmol/L) | 5.23 [4.59; 6.20] | 17 | 5.59 [4.75; 6.03] | 22 | 0.67 |
Serum triacylglycerol (mmol/L) | 1.22 [0.85; 1.75] | 17 | 0.97 [0.81; 1.79] | 22 | 0.60 |
Serum total cholesterol (mmol/L) | 4.42 [3.54; 5.27] | 16 | 3.41 [2.78; 4.61] | 22 | 0.055 |
Serum LDL cholesterol (mmol/L) | 2.96 [1.55; 3.41] | 17 | 1.72 [1.29; 2.24] | 21 | 0.11 |
Serum HDL cholesterol (mmol/L) | 1.04 [0.68; 1.20] | 17 | 0.85 [0.73; 0.98] | 22 | 0.26 |
Data are expressed as mean ± standard error or as median (first quartile; third quartile). Student’s t test was used to compare means and Mann–Whitney test was used to compare median values between WSC and CC patients. WSC—weight-stable cancer patients; CC—cachectic cancer patients. Bold: p value lower than 0.05.